Malaysia

Last Updated 15 October 2021.

7 Vaccines Approved for Use in Malaysia

• Moderna
  mRNA-1273

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 76 countries

  30 trials in 2 countries

  Approval Source: reuters.com

  RNA

• Pfizer/BioNTech
  BNT162b2

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 103 countries

  37 trials in 2 countries

  Approval Source: reuters.com

  RNA

• CanSino
  Ad5-nCoV

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 9 countries

  11 trials in 1 country

  Approval Source: reuters.com

  Non Replicating Viral Vector

• Janssen (Johnson & Johnson)
  Ad26.COV2.S

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 75 countries

  13 trials in 2 countries

  Approval Source: reuters.com

  Non Replicating Viral Vector

• Oxford/AstraZeneca
  AZD1222

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 124 countries

  45 trials in 2 countries

  Approval Source: covid-19.moh.gov.my

  Non Replicating Viral Vector

• Sinopharm (Beijing)
  BBIBP-CorV (Vero Cells)

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 66 countries

  14 trials in 2 countries

  Approval Source: macaubusiness.com

  Inactivated

• Sinovac
  CoronaVac

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 41 countries

  22 trials in 1 country

  Approval Source: reuters.com

  Inactivated

0 Vaccines in Clinical Trials in Malaysia